Application of stable isotope labels for metabolomics in studies in fatty liver disease

Keyphrases

• Metabolomics 100%
• Metabolic Pathway 100%
• Fatty Liver Disease 100%
• Stable Isotope Labeling 100%
• Untargeted Metabolomics 100%
• Untargeted 100%
• Stable Isotopes 50%
• Insulin Resistance 50%
• Cardiovascular Disease 50%
• Mitochondrial Metabolism 50%
• Liver Tissue 50%
• Informatics 50%
• Liver Cells 50%
• Isotopically Labeled 50%
• Cirrhosis 50%
• Non-alcoholic Fatty Liver Disease (NAFLD) 50%
• Genetic Manipulation 50%
• Low Abundance 50%
• Stable Isotope Tracers 50%
• Mass Spectrometry Detection 50%
• Labeled Substrates 50%
• Hepatic Glucose Production 50%
• Liver Metabolism 50%
• Resistance Increase 50%
• Metabolic Substrates 50%
• Fatty Liver 50%
• Product Relationships 50%
• Extraction Separation 50%
• Isotope Tracing 50%
• Whole Liver 50%

Biochemistry, Genetics and Molecular Biology

• Metabolomics 100%
• Metabolic Pathway 66%
• Metabolite 66%
• Mass Spectrometry 33%
• Genetic Manipulation 33%
• Mitochondrial Respiration 33%
• Gluconeogenesis 33%
• Isolated Liver 33%
• Liver Metabolism 33%
• Insulin Resistance 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Stable Isotope 100%
• Fatty Liver 100%
• Liver Cirrhosis 33%
• Nonalcoholic Fatty Liver 33%
• Tracer 33%
• Drug Induced Disease 33%
• Insulin Resistance 33%
• Cardiovascular Disease 33%